FDA Warns Consumers Of Risks Associated With Delta-8 THC Products

16w
3m read
Summary

Delta-8 THC Products Often Contain Harmful Chemicals Because Delta-8 THC is not expressed in sufficient concentrations in most hemp strains to make its extraction financial viable, most Delta-8 THC on the market is derived from the chemical conversion of hemp-derived cannabidiol (“CBD”). RELATED: R.I.P. Delta-8 THC: Why States And DEA Want It Banned In addition, the FDA is denouncing the proliferation of Delta-8 THC products marketed for therapeutic or medical uses despite the lack of FDA approval. In its consumer update, the FDA warned consumers of the following issues about Delta-8 THC products: Photo by Hector Roqueta Rivero/Getty Images Delta-8 THC Products Have Yet to Be Evaluated and Approved by the FDA The agency reminded consumers that Delta-8 THC products have yet to be evaluated or approved by the FDA for safety. On Tuesday, the Food and Drug Administration (the “FDA”) released its first statement via a consumer update regarding Delta-8 tetrahydrocannabinol (“Delta-8 THC”). The agency also fears that many of these products are marketed as “hemp products”, which may lead consumers to assume these products are non-psychoactive.

Article Preview

Hopefully, the steady increase in adverse event reports will finally pressure the FDA to stop kicking the cannabinoids can down the road and forge a legal pathway for these products.

On Tuesday, the Food and Drug Administration (the “FDA”) released its first statement via a consumer update regarding Delta-8 tetrahydrocannabinol (“Delta-8 THC”). The agency decided to provide consumers with key information surrounding the popular cannabinoid following a sharp increase in adverse event reports involving the substance and...

Read the full article @ Fresh Toast